Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie : Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Détails
ID Serval
serval:BIB_CEA996B2B066
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie : Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Périodique
Der Nervenarzt
ISSN
1433-0407 (Electronic)
ISSN-L
0028-2804
Statut éditorial
Publié
Date de publication
05/2019
Peer-reviewed
Oui
Volume
90
Numéro
5
Pages
463-471
Langue
allemand
Notes
Publication types: English Abstract ; Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood serum or plasma to optimize pharmacological therapy. TDM is an instrument with which the high interindividual variability of pharmacokinetics of patients can be identified and therefore enables a personalized pharmacotherapy. In September 2017 the TDM task force of the Working Group for Neuropsychopharmacology and Pharmacopsychiatry (AGNP) published an update of the consensus guidelines on TDM published in 2011. This article summarizes the essential statements for the clinical practice in psychiatry and neurology.
Mots-clé
Neurology, Psychiatry and Mental health, Clinical Neurology, General Medicine, Dose-related reference range, Drug concentration, Neuropsychotropic drugs, Psychopharmacotherapy, Therapeutic reference range
Pubmed
Web of science
Création de la notice
26/11/2018 11:49
Dernière modification de la notice
15/01/2021 6:24